<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d550" origId="Haloperidol"><sentence id="DrugDDI.d550.s0" origId="s0" text="An encephalopathic syndrome (characterized by weakness, lethargy, fever, tremulousness and confusion, extrapyramidal symptoms, leukocytosis, elevated serum enzymes, BUN, and FBS) followed by irreversible brain damage has occurred in a few patients treated with lithium plus HALDOL."><entity id="DrugDDI.d550.s0.e0" origId="s0.p22" charOffset="261-268" type="drug" text="lithium"/><entity id="DrugDDI.d550.s0.e1" origId="s0.p24" charOffset="274-280" type="drug" text="HALDOL"/><pair id="DrugDDI.d550.s0.p0" e1="DrugDDI.d550.s0.e0" e2="DrugDDI.d550.s0.e1" interaction="true"/></sentence><sentence id="DrugDDI.d550.s1" origId="s1" text="A causal relationship between these events and the concomitant administration of lithium and HALDOL has not been established;"><entity id="DrugDDI.d550.s1.e0" origId="s1.p29" charOffset="81-88" type="drug" text="lithium"/><entity id="DrugDDI.d550.s1.e1" origId="s1.p31" charOffset="93-99" type="drug" text="HALDOL"/><pair id="DrugDDI.d550.s1.p0" e1="DrugDDI.d550.s1.e0" e2="DrugDDI.d550.s1.e1" interaction="false"/></sentence><sentence id="DrugDDI.d550.s2" origId="s2" text="however, patients receiving such combined therapy should be monitored closely for early evidence of neurological toxicity and treatment discontinued promptly if such signs appear."/><sentence id="DrugDDI.d550.s3" origId="s3" text="As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics, opiates, and alcohol."><entity id="DrugDDI.d550.s3.e0" origId="s3.p55" charOffset="14-34" type="drug" text="antipsychotic agents"/><entity id="DrugDDI.d550.s3.e1" origId="s3.p60" charOffset="60-66" type="drug" text="HALDOL"/><entity id="DrugDDI.d550.s3.e2" origId="s3.p64" charOffset="98-113" type="drug" text="CNS depressants"/><entity id="DrugDDI.d550.s3.e3" origId="s3.p65" charOffset="122-133" type="drug" text="anesthetics"/><entity id="DrugDDI.d550.s3.e4" origId="s3.p66" charOffset="135-142" type="drug" text="opiates"/><entity id="DrugDDI.d550.s3.e5" origId="s3.p68" charOffset="148-155" type="drug" text="alcohol"/><pair id="DrugDDI.d550.s3.p0" e1="DrugDDI.d550.s3.e0" e2="DrugDDI.d550.s3.e1" interaction="false"/><pair id="DrugDDI.d550.s3.p1" e1="DrugDDI.d550.s3.e0" e2="DrugDDI.d550.s3.e2" interaction="false"/><pair id="DrugDDI.d550.s3.p2" e1="DrugDDI.d550.s3.e0" e2="DrugDDI.d550.s3.e3" interaction="false"/><pair id="DrugDDI.d550.s3.p3" e1="DrugDDI.d550.s3.e0" e2="DrugDDI.d550.s3.e4" interaction="false"/><pair id="DrugDDI.d550.s3.p4" e1="DrugDDI.d550.s3.e0" e2="DrugDDI.d550.s3.e5" interaction="false"/><pair id="DrugDDI.d550.s3.p5" e1="DrugDDI.d550.s3.e1" e2="DrugDDI.d550.s3.e2" interaction="true"/><pair id="DrugDDI.d550.s3.p6" e1="DrugDDI.d550.s3.e1" e2="DrugDDI.d550.s3.e3" interaction="false"/><pair id="DrugDDI.d550.s3.p7" e1="DrugDDI.d550.s3.e1" e2="DrugDDI.d550.s3.e4" interaction="true"/><pair id="DrugDDI.d550.s3.p8" e1="DrugDDI.d550.s3.e1" e2="DrugDDI.d550.s3.e5" interaction="false"/><pair id="DrugDDI.d550.s3.p9" e1="DrugDDI.d550.s3.e2" e2="DrugDDI.d550.s3.e3" interaction="false"/><pair id="DrugDDI.d550.s3.p10" e1="DrugDDI.d550.s3.e2" e2="DrugDDI.d550.s3.e4" interaction="false"/><pair id="DrugDDI.d550.s3.p11" e1="DrugDDI.d550.s3.e2" e2="DrugDDI.d550.s3.e5" interaction="false"/><pair id="DrugDDI.d550.s3.p12" e1="DrugDDI.d550.s3.e3" e2="DrugDDI.d550.s3.e4" interaction="false"/><pair id="DrugDDI.d550.s3.p13" e1="DrugDDI.d550.s3.e3" e2="DrugDDI.d550.s3.e5" interaction="false"/><pair id="DrugDDI.d550.s3.p14" e1="DrugDDI.d550.s3.e4" e2="DrugDDI.d550.s3.e5" interaction="false"/></sentence><sentence id="DrugDDI.d550.s4" origId="s4" text="In a study of 12 schizophrenic patients coadministered oral haloperidol and rifampin, plasma haloperidol levels were decreased by a mean of 70% and mean scores on the Brief Psychiatric Rating Scale were increased from baseline."><entity id="DrugDDI.d550.s4.e0" origId="s4.p72" charOffset="55-71" type="drug" text="oral haloperidol"/><entity id="DrugDDI.d550.s4.e1" origId="s4.p74" charOffset="76-84" type="drug" text="rifampin"/><entity id="DrugDDI.d550.s4.e2" origId="s4.p75" charOffset="93-104" type="drug" text="haloperidol"/><pair id="DrugDDI.d550.s4.p0" e1="DrugDDI.d550.s4.e0" e2="DrugDDI.d550.s4.e1" interaction="true"/><pair id="DrugDDI.d550.s4.p1" e1="DrugDDI.d550.s4.e0" e2="DrugDDI.d550.s4.e2" interaction="false"/><pair id="DrugDDI.d550.s4.p2" e1="DrugDDI.d550.s4.e1" e2="DrugDDI.d550.s4.e2" interaction="false"/></sentence><sentence id="DrugDDI.d550.s5" origId="s5" text="In 5 other schizophrenic patients treated with oral haloperidol and rifampin, discontinuation of rifampin produced a mean 3.3-fold increase in haloperidol concentrations."><entity id="DrugDDI.d550.s5.e0" origId="s5.p89" charOffset="47-63" type="drug" text="oral haloperidol"/><entity id="DrugDDI.d550.s5.e1" origId="s5.p91" charOffset="68-76" type="drug" text="rifampin"/><entity id="DrugDDI.d550.s5.e2" origId="s5.p93" charOffset="97-105" type="drug" text="rifampin"/><entity id="DrugDDI.d550.s5.e3" origId="s5.p96" charOffset="143-154" type="drug" text="haloperidol"/><pair id="DrugDDI.d550.s5.p0" e1="DrugDDI.d550.s5.e0" e2="DrugDDI.d550.s5.e1" interaction="true"/><pair id="DrugDDI.d550.s5.p1" e1="DrugDDI.d550.s5.e0" e2="DrugDDI.d550.s5.e2" interaction="false"/><pair id="DrugDDI.d550.s5.p2" e1="DrugDDI.d550.s5.e0" e2="DrugDDI.d550.s5.e3" interaction="false"/><pair id="DrugDDI.d550.s5.p3" e1="DrugDDI.d550.s5.e1" e2="DrugDDI.d550.s5.e2" interaction="false"/><pair id="DrugDDI.d550.s5.p4" e1="DrugDDI.d550.s5.e1" e2="DrugDDI.d550.s5.e3" interaction="false"/><pair id="DrugDDI.d550.s5.p5" e1="DrugDDI.d550.s5.e2" e2="DrugDDI.d550.s5.e3" interaction="false"/></sentence><sentence id="DrugDDI.d550.s6" origId="s6" text="Thus, careful monitoring of clinical status is warranted when rifampin is administered or discontinued in haloperidol-treated patients."><entity id="DrugDDI.d550.s6.e0" origId="s6.p103" charOffset="62-70" type="drug" text="rifampin"/><entity id="DrugDDI.d550.s6.e1" origId="s6.p108" charOffset="106-117" type="drug" text="haloperidol"/><pair id="DrugDDI.d550.s6.p0" e1="DrugDDI.d550.s6.e0" e2="DrugDDI.d550.s6.e1" interaction="true"/></sentence></document>